IL13 and inflammation: Interestingly, either the overexpression of Nr1d1 or the treatment with its ligand (SR9011) protected mice against lung inflammation in an asthma model (as shown by lung histology, reduced histological scores, IL-4-, IL-5-, and IL-13-levels, as well as reduced GATA3 expression) [37••].